Informed consent was obtained from all subjects. This study was performed in compliance with current Good Clinical Practice (GCP) and was conducted by SeaView Research, Inc., Miami, FL under the review of the Institutional Review Board whose operations are in compliance with Section 56 of Title 21 of the Code of Federal Regulations (CFR).
Effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, an antiretroviral single-tablet regimen for the treatment of HIV infection
Article first published online: 16 NOV 2013
© 2013, The American College of Clinical Pharmacology
The Journal of Clinical Pharmacology
Volume 54, Issue 4, pages 378–385, April 2014
How to Cite
Custodio, J. M., Yin, X., Hepner, M., Ling, K. H. J., Cheng, A., Kearney, B. P. and Ramanathan, S. (2014), Effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, an antiretroviral single-tablet regimen for the treatment of HIV infection. Journal of Clinical Pharma, 54: 378–385. doi: 10.1002/jcph.210
These data were presented in part at the Eleventh International Congress on Drug Therapy in HIV Infection, Glasgow, UK. November 11–15, 2012. All authors are or were employees of Gilead Sciences, Inc.
- Issue published online: 11 MAR 2014
- Article first published online: 16 NOV 2013
- Accepted manuscript online: 19 OCT 2013 03:37AM EST
- Manuscript Accepted: 14 OCT 2013
- Manuscript Received: 7 AUG 2013